BioCentury
ARTICLE | Clinical News

Ameluz aminolevulinic acid regulatory update

May 23, 2016 7:00 AM UTC

FDA approved an NDA from Biofrontera for Ameluz aminolevulinic acid as a photodynamic therapy (PDT) using the BF-RhodoLED lamp for the lesion-directed and field-directed treatment of mild to moderate ...